Literature DB >> 21097788

Treating patients presenting with advanced glaucoma--should we reconsider current practice?

Anthony J King1, Richard E Stead, Alan P Rotchford.   

Abstract

The management of patients presenting with advanced glaucoma presents a challenge to glaucoma clinicians. Presentation with advanced visual field loss is an important risk factor for progression to blindness in the affected eye(s) during the patients' lifetime. Maximising intraocular pressure (IOP) control in such situations is likely to minimise the risk of further visual field deterioration thus either preventing or slowing progression to blindness. Currently most patients presenting with advanced disease in the UK are managed on an escalating regime of medical treatment. Should this fail glaucoma surgery is usually employed to further lower IOP. Although glaucoma surgery is generally a safe and successful intervention it carries a small risk of severe visual loss and is considered by many clinicians as an intervention only to be used following failure of medical treatment. Recently however the National Institute for Clinical Excellence has suggested in its clinical guidelines for management of ocular hypertension and glaucoma that primary surgery should be offered to patients presenting with advanced glaucomatous visual field loss. This is contrary to the practice of most UK ophthalmologists. In this review the current available evidence underlying the management of presentation with advanced disease is examined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097788     DOI: 10.1136/bjo.2010.188128

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Global rates of glaucoma surgery.

Authors:  Kaweh Mansouri; Felipe A Medeiros; Robert N Weinreb
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-09-26       Impact factor: 3.117

Review 2.  Advanced glaucoma: management pearls.

Authors:  Girum W Gessesse; Karim F Damji
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Apr-Jun

3.  Gradually Then Suddenly? Decline in Vision-Related Quality of Life as Glaucoma Worsens.

Authors:  Lee Jones; Susan R Bryan; David P Crabb
Journal:  J Ophthalmol       Date:  2017-04-02       Impact factor: 1.909

4.  Trends in the Retinal Nerve Fiber Layer Thickness Changes with Different Degrees of Visual Field Defects.

Authors:  Wenhui Geng; Dabo Wang; Jing Han
Journal:  J Ophthalmol       Date:  2020-04-12       Impact factor: 1.909

5.  Temporal contrast adaptation in the analysis of visual function in primary open-angle glaucoma.

Authors:  Qianru Wu; Minyue Xie; Xuhao Chen; Di Zhang; Xiaoyong Chen; Ke Xu; Ying Hong; Chun Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-16       Impact factor: 3.535

6.  Structural Change Can Be Detected in Advanced-Glaucoma Eyes.

Authors:  Akram Belghith; Felipe A Medeiros; Christopher Bowd; Jeffrey M Liebmann; Christopher A Girkin; Robert N Weinreb; Linda M Zangwill
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

7.  Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma.

Authors:  Mayuresh Naik; Monika Kapur; VishnuSwarup Gupta; HarinderSingh Sethi; Kartikeya Srivastava
Journal:  Clin Ophthalmol       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.